It has been also shown (in vitro and in vivo) that aprepitant/fosaprepitant increased tumor cell death and decreased tumor cell viability/cell proliferation and tumor volume [16,30] and that NK-1R antagonists induced the death of chemoresistant cancer cells [31]. The gene discussed is TACR1; the disease is cancer.